HighMark Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4K Sell
84
-9
-10% -$286 ﹤0.01% 452
2026
Q1
$2.93K Buy
+93
New +$2.93K ﹤0.01% 431
2025
Q1
– Sell
-141
Closed -$3.56K – 599
2024
Q4
$3.56K Buy
141
+43
+44% +$1.09K ﹤0.01% 404
2024
Q3
$2.44K Buy
98
+11
+13% +$326 ﹤0.01% 469
2024
Q2
$2.59K Hold
87
– – ﹤0.01% 450
2024
Q1
$2.62K Hold
87
– – ﹤0.01% 447
2023
Q4
$2.49K Buy
+87
New +$2.56K ﹤0.01% 450

Other funds holding RTO

HighMark Wealth Management's RTO Position: Q2 2026 in Review

HighMark Wealth Management reduced its Rentokil (RTO) stake by 9.7% in Q2 2026, selling an estimated $286 and leaving 84 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

HighMark Wealth Management first reported a position in RTO in Q4 2023 and has held it in 7 quarters since. The position peaked at $3.56K in Q4 2024. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • HighMark Wealth Management held 84 shares of Rentokil worth $2.4K as of Q2 2026.
  • HighMark Wealth Management sold 9 Rentokil shares in Q2 2026, an estimated $286.
  • Rentokil made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #452 holding.
  • HighMark Wealth Management first reported a position in Rentokil in Q4 2023 and has held it in 7 quarters since.
  • HighMark Wealth Management's Rentokil position peaked at $3.56K in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.